Gregory Alsip
Psychiatry · New York, NYNPI 1346336021
Payments from drug & device makers
Across 321 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$988
- Bausch Health US, LLC$658
- Takeda Pharmaceuticals U.S.A., Inc.$532
- Axsome Therapeutics, Inc.$419
- Otsuka America Pharmaceutical, Inc.$378
- Johnson & Johnson$359
- plus $3K from 25 others
What the payments were for
- Food & beverage$6,18098%
- Education$1102%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,290 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyvanseLisdexamfetamine Dimesylate | 12 | $4,274 |
| Doxepin Hcl | 16 | $3,087 |
| RitalinMethylphenidate Hcl | 16 | $2,725 |
| Bupropion XlBupropion Hcl | 49 | $1,446 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 27 | $1,398 |
| Duloxetine Hcl | 43 | $1,216 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 39 | $1,028 |
| Lamotrigine | 46 | $775 |
| Vilazodone Hcl | 28 | $731 |
| Fluvoxamine Maleate | 13 | $727 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 21 | $668 |
| Buspirone Hcl | 57 | $656 |
| Modafinil | 11 | $655 |
| Clonazepam | 86 | $640 |
| Mirtazapine | 48 | $547 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $532 | $4,27412 claims |
| Almatica Pharma LLCSertraline Hcl | $175 | $52951 claims |
| Lilly USA, LLCOlanzapine | $47 | $40911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in New York
- Michael LiebowitzNew York$7.1M
- Paul EderNew York$2.7M
- Lenard AdlerNew York$1.8M
- Ram ShrivastavaNew York$1.8M
- Jonathan KaneNew York$1.8M
- Eric HollanderNew York$1.4M
- William HapworthNew York$1.3M
- Manish ZinzuvadiaNew York$1.3M
- Jianping ChenNew York$1.2M
- Anthony ZoghbiNew York$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.